These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31356956)

  • 41. Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery.
    Gaspar DP; Gaspar MM; Eleutério CV; Grenha A; Blanco M; Gonçalves LMD; Taboada P; Almeida AJ; Remuñán-López C
    Mol Pharm; 2017 Sep; 14(9):2977-2990. PubMed ID: 28809501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
    Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
    Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
    Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
    Weber S; Zimmer A; Pardeike J
    Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hollow mesoporous hydroxyapatite nanostructures; smart nanocarriers with high drug loading and controlled releasing features.
    Munir MU; Ihsan A; Sarwar Y; Bajwa SZ; Bano K; Tehseen B; Zeb N; Hussain I; Ansari MT; Saeed M; Li J; Iqbal MZ; Wu A; Khan WS
    Int J Pharm; 2018 Jun; 544(1):112-120. PubMed ID: 29678543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative evaluation of carvacrol and eugenol chitosan nanoparticles as eco-friendly preservative agents in cosmetics.
    Mondéjar-López M; López-Jimenez AJ; García Martínez JC; Ahrazem O; Gómez-Gómez L; Niza E
    Int J Biol Macromol; 2022 May; 206():288-297. PubMed ID: 35240208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ
    Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new strategy for battling bacterial resistance: Turning potent, non-selective and potentially non-resistance-inducing biocides into selective ones.
    Ghanbar S; Fumakia M; Ho EA; Liu S
    Nanomedicine; 2018 Feb; 14(2):471-481. PubMed ID: 29183863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Essential oil-loaded lipid nanoparticles for wound healing.
    Saporito F; Sandri G; Bonferoni MC; Rossi S; Boselli C; Icaro Cornaglia A; Mannucci B; Grisoli P; Vigani B; Ferrari F
    Int J Nanomedicine; 2018; 13():175-186. PubMed ID: 29343956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanospray technology for an in situ gelling nanoparticulate powder as a wound dressing.
    De Cicco F; Porta A; Sansone F; Aquino RP; Del Gaudio P
    Int J Pharm; 2014 Oct; 473(1-2):30-7. PubMed ID: 24979533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
    Luo Y; Teng Z; Li Y; Wang Q
    Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
    Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
    Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells.
    Kucukoglu V; Uzuner H; Kenar H; Karadenizli A
    Int J Pharm; 2019 Oct; 569():118578. PubMed ID: 31362096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-drug delivery system based on lipid membrane mimetic coated nano-hydroxyapatite formulations.
    Placente D; Benedini LA; Baldini M; Laiuppa JA; Santillán GE; Messina PV
    Int J Pharm; 2018 Sep; 548(1):559-570. PubMed ID: 30016671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glyceryl monooleate-based otic delivery system of ofloxacin: release profile and bactericidal activity.
    Adwan S; Abu-Dahab R; Al-Bakri AG; Sallam A
    Pharm Dev Technol; 2015 May; 20(3):361-6. PubMed ID: 24392877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gelucire-Based Nanoparticles for Curcumin Targeting to Oral Mucosa: Preparation, Characterization, and Antimicrobial Activity Assessment.
    Hazzah HA; Farid RM; Nasra MMA; Hazzah WA; El-Massik MA; Abdallah OY
    J Pharm Sci; 2015 Nov; 104(11):3913-3924. PubMed ID: 26202796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation.
    Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
    Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.